Jimena S. Miguez
Buenos Aires, C, Argentina
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 59 publications
Implementation of the first adolescence-to-adulthood transition programme for Multiple Sclerosis in Latin America.
Journal: Multiple sclerosis and related disorders
Published: November 18, 2025
Efficacy and safety of Cladribine as a therapeutic option in multiple sclerosis patients over 50 years of age: A real-world study.
Journal: Journal of the neurological sciences
Published: August 11, 2025
Progression independent of relapse activity (PIRA) in the Era of high-efficacy treatments.
Journal: Multiple sclerosis and related disorders
Published: June 10, 2025
Access, satisfaction, adherence and safety to subcutaneous natalizumab compared to intravenous natalizumab in multiple sclerosis in a real-life cohort: first report from Latin America.
Journal: Therapeutic advances in neurological disorders
Published: April 01, 2025
Additional Cladribine tablets treatment courses in multiple sclerosis patients. A retrospective observational study in Latin American countries.
Journal: Multiple sclerosis and related disorders
Published: October 04, 2024
Real-World Effectiveness and Safety of Cladribine in Multiple Sclerosis: Longitudinal Data From the Nationwide Registry in Argentina.
Journal: Clinical neuropharmacology
Published: July 15, 2024
Treatment strategies and responses for attacks of neuromyelitis optica spectrum disorder: A real-world retrospective cohort study.
Journal: Journal of the neurological sciences
Published: May 04, 2024
Traditional first-line treatment failure rates in neuromyelitis optica spectrum disorder patients included in the Argentinean registry (RelevarEM).
Journal: Multiple sclerosis and related disorders
Published: February 26, 2024
Safety of high efficacy therapies in older people with Multiple Sclerosis: A real-world evidence study.
Journal: Multiple sclerosis and related disorders
Published: February 02, 2024
Cladribine use trend in Latin America: the changes in patient profile impact in the drug effectiveness.
Journal: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
Published: January 29, 2024
Selection of disease modifying therapies in multiple sclerosis based on patient's age and disease activity: Data from a nationwide registry.
Journal: Journal of the neurological sciences
Published: October 22, 2023
Mortality of neuromyelitis optica spectrum disorder patients in an Argentinean population: A study from the RelevarEM registry.
Journal: Multiple sclerosis journal - experimental, translational and clinical
Published: July 05, 2023
Last Updated: 09/26/2026